FDA clears TELA Bio's Liora mesh device
TELA Bio received FDA clearance for its Liora Monofilament Scaffold, expanding its product portfolio for soft tissue reconstruction. This marks the first full resorbable synthetic product developed in its ISO 8 certified cleanroom.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed